$NOTV News
Last published 3mo ago
- 3mo agoNOTVInotiv Successfully Completes Financial Restructuring ProcessBusiness WireEmerges from Chapter 11 with a stronger balance sheet, well positioned to execute on its long-term growth initiatives Key senior management continue to lead Inotiv; team remains focused on providing clients with
- 4mo agoNOTVInotiv Announces Confirmation of Plan of ReorganizationBusiness WireMarks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an improved balance sheet and support from key stakeholders Company is poised to execute on long-term
- 5mo agoNOTVInotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future GrowthBusiness WireReceives commitments for $65 million in new money financing to support ongoing business operations Recapitalization effectuated through a pre-packaged plan of reorganization on an expedited basis Transaction is
- 9mo agoNOTVInotiv Provides Notice Regarding Cybersecurity IncidentGlobeNewswireWEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 9mo agoNOTVInotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business UpdateGlobeNewswire– First quarter fiscal 2026 revenue increased 0.8% compared to prior year quarter to $120.9 million – First quarter fiscal 2026 operating loss increased 5.3% compared to prior year quarter to $16.3 million –
- 9mo agoNOTVInotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026GlobeNewswireWEST LAFAYETTE, Ind., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 10mo agoNOTVInotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug DiscoveryGlobeNewswireWEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and
- 11mo agoNOTVInotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics CapabilitiesGlobeNewswireWEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading Contract Research Organization (CRO) specializing in nonclinical and analytical drug discovery
- 11mo agoNOTVInotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business UpdateGlobeNewswire– Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million– Fiscal 2025 revenue increased 4.5% to $513.0 million– Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 million– Fiscal 2025 operating
- 11mo agoNOTVInotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™GlobeNewswireWEST LAFAYETTE, Ind., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Inotiv today announced it ranked 182nd on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications,
- 11mo agoNOTVInotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025GlobeNewswireWEST LAFAYETTE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 11mo agoNOTVInotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year ResultsGlobeNewswirePreliminary Expected Fourth Quarter 2025 Revenue of $137.5 to $138.5 Million Preliminary Expected Full Year 2025 Revenue of $512.5 to $513.5 Million Updated Time of Company Presentation at Jefferies Global Healthcare
- 1y agoNOTVInotiv, Inc. to Participate in Three Investor Conferences in November 2025GlobeNewswireWEST LAFAYETTE, Ind., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 1y agoNOTVInotiv, Inc. to Participate in Three Investor Conferences in September 2025GlobeNewswireWEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 1y agoNOTVInotiv, Inc. (NOTV) Q3 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoNOTVCORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business UpdateGlobeNewswireIn a release issued under the same headline on August 6, 2025 by Inotiv, Inc. (NASDAQ:NOTV), please note that the amount of the recent draw request on the revolving credit facility has been corrected. The corrected
- 1y agoNOTVInotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business UpdateGlobeNewswire– Third quarter fiscal 2025 revenue up 23.5% to $130.7 million– Year-to-date fiscal 2025 revenue increased 4.0% to $374.9 million– Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., Aug. 06, 2025
- 1y agoNOTVInotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025GlobeNewswireWEST LAFAYETTE, Ind., July 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 1y agoNOTVInotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025GlobeNewswireWEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 1y agoNOTVInotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business UpdateGlobeNewswire— Second quarter fiscal 2025 revenue increased 4.4% to $124.3 million— Year-to-date fiscal 2025 revenue declined 4.1% to $244.2 million— Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., May
- 1y agoNOTVInotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025GlobeNewswireWEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 1y agoNOTVInotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business UpdateGlobeNewswireEnhanced liquidity by $27.5 million through the issuance of 6.9 million common sharesFirst quarter fiscal 2025 revenue declined 11.5% to $119.9 millionConference call scheduled for today at 4:30 pm ET WEST
- 1y agoNOTVInotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 MillionGlobeNewswireWEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development
- 1y agoNOTVInotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 MillionGlobeNewswireWEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development
- 1y agoNOTVInotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common SharesGlobeNewswireWEST LAFAYETTE, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development
- 1y agoNOTVInotiv, Inc. Launches Proposed Public Offering of Common SharesGlobeNewswireWEST LAFAYETTE, Ind., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development
- 1y agoNOTVInotiv, Inc. (NOTV) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoNOTVInotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business UpdateGlobeNewswire— Enhanced liquidity through issuance of Second Lien Notes — Obtained amendment to credit agreement and extended note payable — Fourth quarter fiscal 2024 revenue down 7.3% to $130.4 million — Full year fiscal
- 1y agoNOTVInotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™GlobeNewswireWEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inotiv today announced it ranked 138 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life
- 1y agoNOTVInotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024GlobeNewswireWEST LAFAYETTE, Ind., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 2y agoNOTVInotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor ConferencesGlobeNewswireWEST LAFAYETTE, Ind., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 2y agoNOTVInotiv, Inc. Amends Its Credit Agreement and Secures Additional LiquidityGlobeNewswireWEST LAFAYETTE, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 2y agoNOTVInotiv to Participate in the 8th Annual Lake Street Best Ideas Growth ConferenceGlobeNewswireWEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and
- 2y agoNOTVInotiv, Inc. (NOTV) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNOTVInotiv Reports Third Quarter Financial Results for Fiscal 2024 and Provides Business UpdateGlobeNewswire— Third quarter fiscal 2024 revenue down 32.8% to $105.8 million — Year-to-date fiscal 2024 revenue down 16.5% to $360.3 million — Conclusion of certain government investigations — Site optimization projects complete —
- 2y agoNOTVInotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024GlobeNewswireWEST LAFAYETTE, Ind., July 25, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 2y agoNOTVInotiv, Inc. Provides Business UpdatesGlobeNewswireWEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company" or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 2y agoNOTVInotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland FacilityGlobeNewswireWEST LAFAYETTE, Ind., June 03, 2024 (GLOBE NEWSWIRE) -- Inotiv Inc. – Inotiv Inc. ("Inotiv" or the "Company") (NASDAQ:NOTV), a leading contract research organization dedicated to providing nonclinical and analytical
- 2y agoNOTVInotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor ConferencesGlobeNewswireWEST LAFAYETTE, Ind., May 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development
- 2y agoNOTVKirby McInerney LLP Announces Investigation of Shareholder Claims Against Inotiv, Inc. (NOTV)Business WireThe law firm of Kirby McInerney LLP is invest
- 2y agoNOTVInotiv, Inc. (NOTV) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNOTVInotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business UpdateGlobeNewswire— Second quarter fiscal 2024 revenue down 21.5% to $119.0 million— Year-to-date fiscal 2024 revenue down 7.2% to $254.5 million— Agreement in principle reached with the U.S. Department of Justice on related matter— Site
- 2y agoNOTVInvestigation Into Inotiv, Inc. (NOTV) Announced by Holzer & Holzer, LLCGlobeNewswireATLANTA, May 14, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Inotiv, Inc. ("Inotiv" or the "Company") (NASDAQ:NOTV) complied with federal securities laws. On May 13, 2024, Inotiv
- 2y agoNOTVInotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024GlobeNewswireWEST LAFAYETTE, Ind., May 14, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 2y agoNOTVInotiv, Inc. Reschedules its Fiscal 2024 Second Quarter ResultsGlobeNewswireWEST LAFAYETTE, Ind., May 09, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development
- 2y agoNOTVInotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024GlobeNewswireWEST LAFAYETTE, Ind., April 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 2y agoBDNNOTVOLEDRMTIUniversal Display Corporation Announces the Appointment of New Board MembersBusiness WireUniversal Display Corporation (NASDAQ:OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced that Dr. Nigel Brown and Dr. Joan Lau have
- 2y agoNOTVInotiv Reports First Quarter Financial Results for Fiscal 2024 and Provides Business UpdateGlobeNewswire- First quarter fiscal 2024 revenue up 10.3% to $135.5 million - First quarter fiscal 2024 DSA revenue up 8.8% to $44.7 million and RMS revenue up 11.1% to $90.8 million - Shift to a renewed focus on sales and
- 2y agoNOTVInotiv, Inc. to Report Fiscal 2024 First Quarter Financial Results and Host Conference Call on Wednesday, February 7, 2024GlobeNewswireWEST LAFAYETTE, Ind., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and
- 2y agoNOTVInotiv, Inc. (NOTV) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts